🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCagriSema (amylin + semaglutide) — my results so far Page 5

CagriSema (amylin + semaglutide) — my results so far

Dr.NutriCornell Wed, Apr 1, 2026 at 9:59 AM 31 replies 1,170 viewsPage 5 of 7
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Apr 3, 2026 at 2:26 AM#21
josh_phd_bmore said:
Worth knowing that the injection site changes very little.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.

That is the short version; the long version is somebody else's post.

Last edited: Apr 3, 2026 at 4:26 AM
13 13SaraMom3, Dr.MetabolicMD, RetaRick_CA and 10 others
Reply Quote Save Share Report
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Apr 3, 2026 at 12:12 PM#22
josh_phd_bmore said:
Worth knowing that the injection site changes very little.

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

That is the short version; the long version is somebody else's post.

Last edited: Apr 3, 2026 at 2:12 PM
12 12hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 9 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Apr 3, 2026 at 9:58 PM#23
josh_phd_bmore said:
Worth knowing that the injection site changes very little.

That reframing is the part I needed. I will report back once I have actually tried it.

11 11EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Apr 4, 2026 at 7:44 AM#24

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

10 10tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 7 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Apr 4, 2026 at 5:29 PM#25
Dr.SleepRoch said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Mine went the same way, slower. Nothing to add that would improve it.

9 9Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 6 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register